Delivery Order SPE2DB20D9129-SPE2DB22FC5MQ
Award Date
4/20/22
Potential Completion Date
4/21/22
Potential Value
$599
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,954.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/20 ml vials of ropivacaine hydrochloride injection 1%. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for a single day of delivery on July 18, 2023 to fulfill DLA requirements, with no subcontractors involved. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this...
The Defense Logistics Agency awarded a $2,340 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a sterile injectable anesthetic. The contract calls for Amerisourcebergen to deliver 200 ml of the anesthetic from its facility in Conshohocken, Pennsylvania to an unknown customer by June 26, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for...
The Defense Logistics Agency awarded a $244,950 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ropivacaine hydrochloride injection USP, 0.5% 150 mg/30 mL single-dose vials. The contract calls for the delivery of 30 mL vials of the specified anesthetic to a facility in Conshohocken, Pennsylvania by June 30, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. military and other government agencies, this award supports the Defense Logistics...
This is a federal delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 400 mg/200 mL ropivacaine 0.2% in 200 mL doses, with a ceiling value of $6,449.98 and a completion date of June 18, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
The Defense Logistics Agency awarded a $4,324.60 firm fixed price delivery order to Amerisourcebergen Drug Corp for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. The single delivery is scheduled to take place between August 24-25, 2023. No subcontractors or set aside designations were indicated....
The Defense Logistics Agency awarded a $3,664 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the analgesic medication from its Conshohocken, Pennsylvania facility to support DLA requirements. No major subcontractors or set aside designations were indicated. This award draws from DLA's indefinite-delivery/indefinite-quantity pharmaceutical contracts to supply medical...
The Defense Logistics Agency awarded a $3,509 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the analgesic drug from its Conshohocken, Pennsylvania facility to support DLA requirements. No major subcontractors or set aside designations were indicated. This award draws from DLA's indefinite delivery vehicle for pharmaceuticals to supply military treatment facilities and...
The Defense Logistics Agency awarded a $2,004.51 firm fixed price delivery order to Amerisourcebergen Drug Corp for 400 mg/200 ml vials of ropivacaine hydrochloride 0.2% injection. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by August 25, 2023. No subcontractors or set aside designations were identified. This order is likely in support of DLA's medical supply...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,237 to Amerisourcebergen Drug Corporation to supply 4562179154, which is ropivacaine hydrochloride 0.2% solution in 400mg/200ml vials. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 14 through 15, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ropivacaine 0.2% 400 mg/200 ml medical products. The order has a firm fixed price of $1,749.64 and a completion date of January 28, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...